MetaMask Launches AI Agent Wallet With Built-In Security Controls
MetaMask's new self-custodial wallet is designed to let AI agents trade across DeFi while keeping users in control of funds and ap...
MetaMask launches AI agent wallet with built-in security for crypto trades
The launch comes as AI agents increasingly emerge as participants in crypto markets, executing trades and managing capital on beha...
Bitmine bought the dip, making its biggest ether purchase in 2026 as prices tank...
The company bought 126,971 ETH last week, worth roughly $214 million at current prices, despite chairman Tom Lee's earlier calls t...
Tesla (TSLA) Stock Climbs as SpaceX IPO Demand Falls Short of Expectations
Tesla (TSLA) climbed 1.4% Monday while SpaceX's $75B IPO attracted two-times oversubscription, falling short of Wall Street's succ...
Bitcoin's $63K Reclaim Liquidates $540M in Crypto Shorts, a 7-Week High
Experts remain cautious of Bitcoin’s weekend rebound to $63,000, pointing to ETF outflows and CME BTC volatility.
Monday’s Stock Winners: Eli Lilly (LLY), Nurix (NRIX), and Broadcom (AVGO) Rally
Eli Lilly stock jumps on Foundayo obesity trial results, Nurix surges 38% on $2.3B Roche deal, and AI chip stocks recover from Fri...
XRP Price Prediction: Only BTC and XRP Have Survived the Top 10 Since 2014
XRP price is not looking good, but history shows that only Bitcoin and XRP have held top-10 market cap positions since 2014. It is...
Battalion Oil (BATL) Stock Soars in Premarket on Middle East Tensions and Rising...
Battalion Oil (BATL) stock jumped up to 48.5% premarket as Israeli strikes on Iran pushed Brent crude above $97, triggering a rall...
American Battery Technology (ABAT) Stock Soars 30% as DOE Restores $115M Lithium...
American Battery Technology (ABAT) stock surged 30% after successfully appealing the DOE's grant termination, restoring $115M in f...
Nurix Therapeutics (NRIX) Stock Drops as Roche Announces $2.3 Billion Cancer Dru...
Nurix Therapeutics (NRIX) partners with Roche in $2.3B deal for blood cancer drug bexobrutideg. $700M upfront, Phase III trials be...